Abstract
It is now well known that a cardiomyopathic state accompanies diabetes mellitus. Although insulin injections and conventional hypoglycemic drug therapy have been of invaluable help in reducing cardiac damage and dysfunction in diabetes, cardiac failure continues to be a common cause of death in the diabetic population. The use of alternative medicine to maintain health and treat a variety of diseases has achieved increasing popularity in recent years. The goal of alternative therapies in diabetic patients has been to lower circulating blood glucose levels and thereby treat diabetic complications. This paper will focus its discussion on the role of vanadium on diabetes and the associated cardiac dysfunction. Careful administration of a variety of forms of vanadium has produced impressive long-lasting control of blood glucose levels in both Type 1 and Type 2 diabetes in animals. This has been accompanied by, in many cases, a complete correction of the diabetic cardiomyopathy. The oral delivery of vanadium as a vanadate salt in the presence of tea has produced particularly impressive hypoglycemic effects and a restoration of cardiac function. This intriguing approach to the treatment of diabetes and its complications, however, deserves further intense investigation prior to its use as a conventional therapy for diabetic complications due to the unknown long-term effects of vanadium accumulation in the heart and other organs of the body.
Similar content being viewed by others
References
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997. JAMA 280:1569–1575
Grauds C (1997) Botanicals: strong medicine for health and profit. Assoc Natl Med Pharm 3:1
Vann A (1998) The herbal medicine boom: understanding what patients are taking. Cleveland Clin J Med 65(3):129–134
Harris WS, Isley WL (2001) Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids. Curr Atheroscler Rep 3(2):174–179
Peirce A (1999) Natural medicines. Stonesong Press, New York
Harbowy ME, Balentine DA (1997) Tea Chemistry. Crit Rev Plant Sci 16(5):415–480
Beart JE, Lilley TH, Haslam E (1985) Plant polyphenols: secondary metabolism and chemical defence. Phytochem 24:33–38
Dufresne CJ, Farnworth ER (2001) A review of latest research findings on the health promotion properties of tea. J Nutr Biochem 12(7):404–421
Zeyuan D, Bingying TXL, Jinming C, Yifeng C (1998) Effect of green tea and black tea on the blood glucose, the blood triglycerides, and antioxidation in aged rats. J Agric Food Chem 46:875–878
Shimizu M (1999) Modulation of the intestinal function by food substances. Nahrung 43:154–158
Wiseman SA, Balentine DA, Frei B (1997) Antioxidants in tea. Crit Rev Food Sci Nutr 37:705–718
Vinson JA, Jang J, Dabbagh YA, Serry M, Cai S (1995) Plant polyphenols exhibit lipoprotein bound antioxidant activity using an in vitro oxidation model for heart disease. J Agric Food Chem 43:2798–2799
Yokozawa T, Dong E, Nakagawa T, Kim DW, Hatori M, Nakagawa H (1998) Effects of Japanese black tea on atherosclerotic disorders. Biosci Biotechnol Biochem 62(1):44–48
Yokozawa T, Oura H, Nakagawa H, Sakanaka S, Kim M (1995) Effects of a component of green tea on the proliferation of vascular smooth muscle cells. Biosci Biotechnol Biochem 59(11):2134–2136
Pearson DA, Frankel EN, Aeschbach R, German JB (1998) Inhibition of endothelial cell mediated low-density lipoprotein oxidation by green tea extracts. J Agric Food Chem 62:44–48
Yang TT, Koo MW (1997) Hypocholesterolemic effects of Chinese tea. Pharmacol Res 35(6):505–512
Lin YL, Cheng CY, Lin YP, Lau YW, Lau YW, Juan IM, Lin JK (1998) Hypolipidemic effect of green tea leaves through induction of anti-oxidant and phase II enzymes including superoxide dismutase, catalase and glutathione S-transferase in rats. J Agric Food Chem 46:1893–1899
Deniset JF, Pierce GN (2010) The value of therapeutic interventions in disrupting Chlamydophila pneumonia involvement in cardiovascular disease. Fundamental Clin Pharmacol 24:607–617
Tijburg LB, Mattern T, Folts JD, Weisgerber UM, Katan MB (1997) Tea flavonoids and cardiovascular disease: a review. Crit Rev Food Sci Nutr 37(8):771–785
Tijburg LGM, Chio JH, Rhee SJ (1999) Effects of green tea catechin on phospholipase A2 activity and antithrombus in streptozotocin diabetic rats. J Nutr Sci Vitaminol 45:337–346
Yokozawa T, Chung HY, He LQ, Oura H (1996) Effectiveness of green tea tannin on rats with chronic renal failure. Biosci Biotechnol Biochem 60(6):1000–1005
Yokozawa T, Oura H, Sakanaka S, Ishigaki S, Kim M (1994) Depressor effect of tannin in green tea on rats with renal hypertension. Biosci Biotech Biochem 58:855–858
Yokozawa T, Nakagawa T, Lee KI, Cho EJ, Terasawa K, Takeuchi S (1999) Effects of green tea tannin on cisplatin-induced nephropathy in LLD-PK1 cells and rats. J Pharm Pharmacol 51(11):1325–1331
Hindmarch I, Quinlan PT, Moore KL, Parkin C (1998) The effects of black tea and other beverages on aspects of cognition and psychomotor performance. Psychopharmacology 139(3):230–238
Joseph JA, Denisova N, Fisher D, Shukitt-Hale B, Bickford P, Prior R, Cao G (1998) Membrane and receptor modifications of oxidative stress vulnerability in aging: nutritional considerations. Ann N Y Acad Sci 854:268–276
Junuja LR, Chu DC, Ocubo T, Nagato Y, Yokogoshi H (1999) L-theanine-a unique amino acid of green tea and its effects in humans. Trends Food Sci Technol 10:199–204
Nriagu Jo (1998) Vanadium in the environment. In: Advances in environmental science and technology, Vol. 30, 31. Wiley, New York
Tracey AS, Crans DC (1998) Vanadium compounds. Chemistry, biochemistry and therapeutic applications. Oxford University Press, London
Harland BF, Harden-Williams BA (1994) Is vanadium of human nutritional importance yet? J Am Diet Assoc 94(8):891–894
French RJ, Jones PJ (1993) Role of vanadium in nutrition: metabolism, essentiality and dietary considerations. Life Sci 52(4):339–346
Anke M, Groppel B, Gruhn K, Kosla T, Szilagyi M (1986) In: Anke M, Baumann W, Braunlich H, Bruckner C, Groppel B (eds) Spurenelement-symposium New Trace Elements, Friedrich-Schiller-Universitat Jena, pp 1266–1275
Nielsen FH, Poellot RA, Uthus EO (1997) FASEB J 11: A148 (abs862)
Nielsen FH (1995) Vanadium and its role in life. In: Sigel H, Sigel A (eds) Metal ions and biological systems, vol 31. Marcel Dekkar, New York, pp 543–573
Ikebe K, Tanaka R (1979) Determination of vanadium and nickel in marine samples by flameless and flame atomic absorption spectrophotometry. Bull Environ Contam Toxicol 21(4–5):526–532
Myron DR, Givand SH, Nielsen FH (1977) Vanadium content of selected foods as determined by flameless atomic absorption spectroscopy. J Agric Food Chem 25(2):297–300
Byrne AR, Kosta L (1978) Vanadium in foods and in human body fluids and tissues. Sci Total Environ 10(1):17–30
Nielsen FH (1995) Metal-ligand interactions in biological fluids, bioinorganic medicine, Vol 1. Marcel Dekkar, New York, pp 425–427
Bodgen JD, Higashino H, Lavenhar MA, Bauman Jw Jr, Kemp FW, Aviv A (1982) Balance and tissue distribution of vanadium after short-term ingestion of vanadate. J Nutr 10(2):233–245
Wiegmann TB, Day HD, Patak RV (1982) Intestinal absorption and secretion of radioactive vanadium *48VO3) in rats and effect of Al(OH)3. J Toxicol Environ Health 10(2):233–245
Chasteen ND, Lord EM, Thompson HF (1986) In Frontiers in Bioinorganic Chemistry; Xavier AV (ed) VCH Verlagsgesellschaft, Weinhem, FRG, pp 133–41
Cantley LC Jr, Resh MD, Guidotti G (1978) Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side. Nature 272(5653):552–554
Chasteen ND, Lord EM, Thompson HJ, Grady JK (1986) Vanadium complexes of transferrin and ferritin in the rat. Biochem Biophys Acta 884(1):84–92
Sabbioni E, Marafante E (1981) In: Howell J, Gawthorne JM, White CL (eds) Trace element metabolism in man and animals (TEMA-4). Australian Academy of Science, Canberra, pp 629–631
Patterson BW, Hansard SL 2nd, Ammerman CB, Henry PR, Zech LA, Fisher WR (1986) Kinetic model of whole-body vanadium metabolism: studies in sheep. Am J Physiol 251(2 Pt 2):R325–R332
Hopkins LL Jr, Tilton BE (1966) Metabolism of trace amounts of vanadium 48 in rat organs and liver subcellular particles. Am J Physiol 211(1):169–172
Poucheret P, Verma S, Grynpas MD, McNeill JH (1998) Vanadium and diabetes. Mol Cell Biochem 188(1–2):73–80
Shisheva A, Ikonomov O, Shechter Y (1994) The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinology 134(1):507–510
Stern A, Yin X, Tsang SS, Davison A, Moon J (1993) Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71(3–4):103–112
Sekar N, Li J, Shechter Y (1996) Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Crit Rev Biochem Mol Biol 31(5–6):339–359
Want H, Scott RE (1995) Unique and selective mitogenic effects of vanadate on SV40-transformed cells. Mol Cell Biochem 153(1–2):59–67
Sabbioni E, Pozzi G, Pintar A, Casella L, Garattini S (1991) Cellular retention, cytotoxicity and morphological transformation by vanadium(IV) and vanadium (V) in BALB/3T3 cell lines. Carcinogenesis 12(1):47–52
Sabbioni E, Pozzi G, Devos S, Pintar A, Casella L, Fischbach M (1993) The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV). Carcinogenesis 14(12):2565–2568
Etcheverry SB, Crans DC, Keramidas AD, Cortizo AM (1997) Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch Biochem Biophys 338(1):7–14
Barrio DA, Braziunas MD, Etcheverry SB, Cortizo AM (1997) Maltol complexes of vanadium (IV) and (V) regulate in vitro alkaline phosphatase activity and osteoblast-like cell growth. J Trace Elem Med Biol 11(2):110–115
Cortizo AM, Salice VC, Vescina CM, Etcheverry SB (1997) Proliferative and morphological changes induced by vanadium compounds on Swiss 3T3 fibroblasts. Biometals 10(2):127–133
Cortizo AM, Etcheverry SB (1995) Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol Cell Biochem 145(2):97–102
Shecter Y, Shisheva A (1993) Vanadium salts and the future treatment of diabetes. Endeavour 17(1):27–31
McNeill JH, Yuen VG, Dai S, Orvig C (1995) Increased potency of vanadium using organic ligands. Mol Cell Biochem 153(1–2):175–180
Cam MC, Cros GH, Serrano JJ, Lazaro R, McNeill JH (1993) In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes. Diabetes Res Clin Pract 29(2):111–121
Reul BA, Amin SS, Buchet JP, Ongemba LN, Crans DC, Brichard SM (1999) Effects of vanadium complexes with organic ligands on glucose metabolism; a comparison study in diabetic rats. Br J Pharmacol 126(2):467–477
Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS et al (1994) Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269(6):4596–4604
Bevan AP, Drake PG, Yale JF, Shaver A, Posner BI (1995) Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis. Mol Cell Biochem 153(1–2):49–58
Gupta D, Raju J, Baquer NZ (1999) Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: effect of antidiabetic compounds. Indian J Exp Biol 37(2):196–199
Mooney RA, Bordwell KL, Luhowskyj S, Casnellie JE (1989) The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation. Endocrinology 124(1):422–429
Strout HV, Vicario PP, Saperstein R, Slater EE (1989) The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. Endocrinology 124(4):1918–1924
Fantus IG, Ahmad F, Deragon G (1994) Vanadate augments insulin-stimulated insulin receptor Kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Diabetes 43(3):375–383
D’Onofrio F, Le MQ, Chiasson JL, Srivastava AK (1994) Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation. FEBS Lett 340(3):269–275
Shisheva A, Shechter Y (1992) Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. Biochemistry 31(34):8059–8063
Ui M, Okada T, Hazeki K, Hazeki O (1995) Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem Sci 20(8):303–307
Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P (1994) The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 303(pt 1):21–26
Elberg G, He Z, Li J, Sekar N, Shechter Y (1997) Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes 46(11):1684–1690
Shisheva A, Shechter Y (1993) Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. J Biol Chem 268(9):6463–6469
Nielsen F, Uthus E (1990) The essentiality and metabolism of vanadium. In: Chasteen ND (ed) Vanadium in biological systems. Kluwer, Dordrecht, pp 51–62
Nielsen FH (1998) The nutritional essentiality and physiological metabolism of vanadium in higher animals. In: Vanadium compounds, American Chemical Society, Washington, pp 297–307
Heyliger CE, Tahiliani AG, McNeill JH (1985) Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227(4693):1474–1477
Becker DJ, Ongemba LN, Henquin JC (1994) Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats. Eur J Pharmacol 260(2–3):169–175
Pederson RA, Ramanadham S, Buchan AM, McNeill JH (1989) Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. Diabetes 38(11):1390–1395
Clark TA, Heyliger CE, Kopilas M, Edel AL, Junaid A, Aguilar F, Smyth DD, Thliveris JA, Merchant ME, Kim HK, Pierce GN (2012) A tea/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity. Metabolism 61(5):742–753
Fantu IG, Deragon G, Lai R, Tang S (1996) The insulin-mimetic agent vanadate promotes receptor endocytosis and inhibits intracellular ligand-receptor degradation by a mechanism distinct from the lysosomotropic agents. Diabetes 45(8):1084–1093
Pugazhenthi S, Hussain A, Yu B, Brownsey RW, Angel FJ, Khandelwal RL (1995) Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zudker Rat. Mol Cell Biochem 153(1–2):211–215
Brichard SM, Ongemba LN, Kolanowski J, Henquin JC (1991) The influence of vanadate on insulin counter-regulatory hormones in obese fa/fa rats. J Endocrinol 131(2):185–191
Fantus IG, Tsiani E (1998) Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects. Mol Cell Biochem 182(1–2):109–119
Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR (1995) In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem 153(1–2):217–231
Orvig C, Thompson KH, Battell M, McNeill JH (1995) Vanadium compounds as insulin mimics. Met Ions Biol Syst 31:575–594
Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J (1990) Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126(5):2728–2732
Kopp SJ, Daar J, Paulson DJ, Romano FD, Laddaga R (1997) Effects of oral vanadyl treatment on diabetes-induced alterations in the heart GLUT-4 transporter. J Mol Cell Cardiol 29(9):2355–2362
Li SH, McNeill JH (2001) In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats. Mol Cell Biochem 217(1–2):121–129
Hajduch E, Karakhshan F, Hundal HS (1998) Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes. Diabetologia 41(7):821–828
Ding W, Hasegawa T, Hosaka H, Peng D, Takahashi K, Sedo Y (2001) Effect of long-term treatment with vanadate in drinking water on KK mice with genetic non-insulin-dependent diabetes mellitus. Biol Trace Elem Res 80(2):159–174
Gupta D, Raju J, Prakash J, Baquer NZ (1999) Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes Res Clin Pract 46(1):1–7
Sekar N, Grovindasamy S (1991) Effects of vanadate on plasma lipoprotein profiles in experimental diabetic rats. Biochem Int 23(5):935–940
Seranno Rios M (2001) Epidemiology of cardiovascular disease in type 2 diabetes. Int J Clin Pract Suppl 121:4–7
Janka HU (1996) Increased cardiovascular morbidity and mortality in diabetes mellitus: identification of the high risk patient. Diabetes Res Clin Pract 30(Suppl):85–88
Clark TA, Pierce GN (2000) Cardiovascular complications of non-insulin-dependent diabetes: the JCR:LA-cp rat. J Pharmacol Toxicol Methods 43:1–10
Pierce GN, Russell JC (1997) Regulation of intracellular Ca2+ in the heart during diabetes. Cardiovasc Res 34:41–47
Pierce GN, Russell JC, Maddaford TG (1997) Cardiovascular dysfunction in insulin-dependent and non-insulin dependent diabetic animals. Can J Physiol Pharmacol 75:343–350
Clark TA, Maddaford TG, Tappia PS, Heyliger CE, Ganguly PK, Pierce GN (2010) Restoration of cardiomyocyte function in streptozotocin-induced diabetic rats after treatment with vanadate in a tea decoction. Curr Pharm Biotechnol 11:906–910
Tappia PS, Maddaford TG, Hurtado C, Dibrov E, Austria JA, Sahi N, Panagia V, Pierce GN (2004) Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy. Biochem Biophys Res Commun 316:280–289
Ozcelikay AT, Yidizoglu-Ari N, Ozuari A, Ozturk Y, Altan VM (1993) The effect of vanadate on alloxan-diabetic rat atria. Diabetes Res Clin Pract 19(3):189–194
Matsubara T, Musat-Marcu S, Misra HP, Dhalla NS (1995) Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart. Mol Cell Biochem 153(1–2):79–85
Sekar N, Kanthasamy A, William S, Balasubramaniyan N, Govindasamy S (1990) Antioxidant effect of vanadate on experimental diabetic rats. Acta Diabetol Lat 27(4):285–293
Levy E, Bendayan M (1991) Lipoprotein lipase in experimental diabetic rats: beneficial effect of vanadate treatment. Diabete Metab 17(1):44–48
Hopfner RL, Misurski D, Wilson TW, McNeill JR, Gopalakrishnan V (1998) Insulin and vanadate restore decreased plasma endothelin concentrations and exaggerated vascular responses to normal in the streptozotocin diabetic rat. Diabetologia 41(10):1233–1240
Clark TA, Edel AL, Heyliger CE, Pierce GN (2004) Effective control of glycemic status and toxicity in Zucker Diabetic Fatty rats with an orally administered vanadate compound. Can J Physiol Pharmacol 82:888–894
Clark TA, Heyliger CE, Goel DP, Pierce GN (2004) The use of tea as a non-toxic modality to deliver vanadate to streptozotocin-induced diabetic rats. Metabolism 53:1145–1151
Srivastava AK (2000) Anti-diabetic and toxic effects of vanadium compounds. Mol Cell Biochem 206(1–2):177–182
Domingo JL (1996) Vanadium: a review of the reproductive and developmental toxicity. Reprod Toxicol 10(3):175–182
Gil J, Miralpeix M, Carreras J, Bartrons R (1987) Insulin like effects of vanadate on glucokinase activity and fructose-2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem 262:6658–6662
Brichard SM, Okitolonda W, Henquin JC (1998) Long-term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123:2048–2053
Blondel O, Bailbe D, Portha B (1989) In vivo insulin resistance in streptozotocin diabetic rats: evidence for reversal following oral vanadate treatment. Diabetologia 32:185–190
Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH (1989) Oral vanadyl sulphate in treatment of diabetes mellitus in rats. Am J Physiol 257:H904–H911
Sakurai H, Tsuchiya K, Nakatsuka M, Sofue M, Kawada J (1990) Insulin-like effects of vanadyl ion in streptozotocin induced diabetic rats. J Endocrinol 126:451–459
Dai S, Thompson KH, Vera E, McNeill JH (1994) Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate. Pharmacol Toxicol 75(5):265–273
Domingo JL, Gomez M, Sanchez DJ, Llobet JM, Keen CL (1994) Relationship between reduction in food intake and amelioration of hyperglycemia by oral vanadate in STZ-induced diabetic rats. Diabetes 43(10):1267, 1269–1270
Ganguli S, Reuland DJ, Franklin LA, Tucker M (1994) Effect of vanadate on reproductive efficiency in normal and streptozotocin-treated diabetic rats. Metabolism 43(11):1384–1388
Ganguli S, Reuland DJ, Franklin LA, Deakins DD, Johnston WJ, Pasha A (1994) Effects of maternal vanadate treatment of fetal development. Life Sci 55(16):1267–1276
Mongold JJ, Cros HG, Vian L, Tep A, Ramanadham S, Siou G, Diaz J, McNeill JH, Serrano JJ (1990) Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology. Pharmacol Toxicol 67(3):192–198
Edel AL, Kopilas M, Clark TA, Aguilar F, Ganguly PK, Heyliger CE, Pierce GN (2006) Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats. Metabolism 55(2):263–270
Pugazhenthi S, Mantha SV, Khandelwal RL (1990) Decrease of liver protein kinase C in streptozotocin-induced diabetic rats and restoration by vanadate treatment. Biochem Int 21(4):651–657
Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR (1995) Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80:3311–3320
Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L (1995) Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 95:2501–2509
Boden G, Chen Z, Ruiz J, Van Rossum GDV, Turco S (1996) Effects of vanadyl sulfate on carbohydrate and lipid metabolism inpatients with non-insulin-dependent diabetes mellitus. Metabolism 45:1130–1135
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997. JAMA 280:1569–1575
Manya K, Champion B, Dunning T (2012) The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med 12:2. doi:10.1186/1472-6882-12-2
Xie W, Zhao Y, Gu D, Du L, Cai G, Zhang Y (2011) Scorpion in combination with gypsum: novel antidiabetic activities in streptozotocin-induced diabetic mice by up-regulating pancreatic PPARy and PDX-1 Expressions. Evid Based Complement Alternat Med 2011:683561
El-Sayed MI (2011) Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternate therapy. J Ethnopharmacol 137(1):643–651
Xie W, Zhao Y, Zhang Y (2011) Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus. Evid Based Complement Alternat Med 2011:726723
Tam TW, Liu R, Arnason JT, Krantis A, Staines WA, Haddad PS, Foster BC (2011) Cree antidiabetic plant extracts display mechanism-based inactivation of CYP3A4. Can J Physiol Pharmacol 89(1):13–23
Ogbera AO, Dada O, Adeyeye F, Jewo PL (2010) Complementary and alternative medicine use in diabetes mellitus. West Afr J Med 29(3):158–162
Prasad K (2001) Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med 138(1):32–39
Acknowledgments
This work was supported by a grant from the Heart and Stroke Foundation of Canada and through indirect support from St Boniface Hospital Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clark, T.A., Deniset, J.F., Heyliger, C.E. et al. Alternative therapies for diabetes and its cardiac complications: role of vanadium. Heart Fail Rev 19, 123–132 (2014). https://doi.org/10.1007/s10741-013-9380-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-013-9380-0